𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Short term safety and efficacy of famciclovir in prevention of CMV infection in liver transplant recipients

✍ Scribed by Rabkin, John M.; Orloff, Susan L.; Corless, Christopher L.; Benner, Kent G.; Flora, Ken D.; Rosen, Hugo R.; Olyaei, Ali J.

Book ID
121993027
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
158 KB
Volume
114
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of low-dose valganci
Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients
✍ Jeong M. Park; Kathleen D. Lake; Juan D. Arenas; Robert J. Fontana πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

The efficacy and safety of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant recipients has not been established. We retrospectively compared the efficacy and safety of low-dose oral VGCV (450 mg once daily for 90 days) and standard oral ganciclovir (1 g three times a d

Question of using valganciclovir for cyt
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients
✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n Ο­ 49) compared with the standard dose of ganciclovir (n Ο­ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au